Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India

Tropical Doctor

Volumn 39, Issue 1, 2009, Pages 28-30

  Gupta, Varsha ^a   Kaur, Jaspal ^a   Kaistha, Neelam ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; INDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA ENTERICA; SEROTYPE; TYPHOID FEVER; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SALMONELLA TYPHI;

SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI;

ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 64549107565     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/td.2008.070452     Document Type: Article

References (10)

1. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth International Supplement. Wayne, Pennsylvania, USA. National Committee for Clinical Laboratory Standards. 2006 (M100-S16)
2. Manchanda V, Bhall P, Sethi M, Sharma VK. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serotype Typhi and Paratyphi A. Ind J Med Microbiol 2006;24:101-106 (Pubitemid 43747890)
3. Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: randomized trial of a a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hyg 1995;52:162-165
4. Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increase of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002;129:29-34 (Pubitemid 34906183)
5. Mathai D, Kudvu GC, Keystone JS, et al. Short course ciprofloxacin therapy for enteric fever. J Assoc Physicians India 1993;41:428-430
6. Biswal N, Mathai B, Bhatia BD, Srinivasan S, Nalini P. Enteric fever: a changing perspective. Indian Pediatr 1994;31:813-819 (Pubitemid 24236583)
7. Kumar R, Sazawal S, Sinha A, Sood S, Bhan MK. Typhoid Fever: Contemporary Issues as Related to Disease in India. Round Table Conference Series on Water Borne Disease, Ranbaxy Science Foundation, New Delhi 1997;2:31-36
8. Crump JA, Kretsinger K, Gay K, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States Food Net multi-center retrospective cohort study. Antimicrob Agents Chemother 2008;52:1278-1284
9. Bhutta ZA, Khan IA, Shadmani M. Failure of short-course ceftriaxone chemotherapy for Multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan. Antimicrob Agents Chemother 2004;44;450-452
10. Jesudason MV, Malathy B, John TJ. Trend of increasing minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi. Ind J Med Res 1996;103:247-249 (Pubitemid 26164492)